Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-810-4 | CAS number: 7747-35-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was not conducted according to guideline/s and GLP but the report contains sufficient data to permit a meaningful evaluation of study results
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- A series of single 4-hour inhalation whole-body exposures was performed in which Zoldine ZE-P-1601 was administered as an aerosol in the breathing zone of Sprague-Dawley rats in order to determine the median lethal concentration (LD50)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole
- EC Number:
- 231-810-4
- EC Name:
- 7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole
- Cas Number:
- 7747-35-5
- Molecular formula:
- C7H13NO2
- IUPAC Name:
- 7a-ethyl-tetrahydro-1H-[1,3]oxazolo[3,4-c][1,3]oxazole
- Details on test material:
- - Name of test material (as cited in study report): Zoldine ZE (BIOBANTMCS-1246 Antimicrobial)
- Physical state: Dark yellow clear liquid
- Analytical purity: 96.84% determined by gas chromatography
- Lot/batch No.: # 1
- Stability under test conditions: Stable at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Wilmington, MASS
- Age at study initiation: Not specified
- Weight at study initiation: Males 201-299 grams, Females 203-249 grams
- Fasting period before study: Not specified
- Housing: Individually housed in elevated, stainless steel and wire mesh cages.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 14 days
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus:
A 250 ml reservoir containing the test material was connected to an FMI fluid metering pump (Model #RPG-20). The test material was fed directly into an air atomizing nozzle (spraying systems company; ¼” J nozzle) and dry air at a flow rate of 19 liters per minute was passed through the atomizer to generate the aerosol. The test atmosphere was directed, undiluted, into a 100-liter Plexiglas exposure chamber, which housed the animals. The chamber concentration for each exposure group was achieved by changing the FMI pump setting.
- Exposure chamber volume:
100-liter
- Method of holding animals in test chamber:
The animals were individually housed in elevated; stainless steel and wire mesh cages.
- System of generating particulates/aerosols:
The test material was fed directly into an air atomizing nozzle (spraying systems company; ¼” J nozzle) and dry air at a flow rate of 19 liters per minute was passed through the atomizer to generate the aerosol.
- Method of particle size determination:
Particle size was measured for each exposure using a cascade impactor, and the mass median aerodynamic diameter (MMAD) was calculated.
TEST ATMOSPHERE
- Brief description of analytical method used:
During each exposure chamber air samples were collected using a glass fiber filter at approximately hourly intervals at a rate of 4.9 liters per minute for 30 seconds. The amount of material collected as an aerosol was determined gravimetrically by weighing the filter holder and filter paper before and after sampling and dividing the difference in weights by the sample volume.
- Samples taken from breathing zone: yes - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0, 1.6, 2.4, 2.6, 3.3, 4.3 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- Single, four-hour whole-body aerosol exposures were conducted with 5 male and 5 female Sprague-Dawley rats in order to determine the median lethal dose. Rats were obtained from a commercial supplier. They were group housed during a 14-day acclimation period to the laboratory. They were housed individually and identified by metal ear tag after assignment to study. They were given food and water ad libitum during their stay in the testing facility.
Chamber monitoring was accomplished by gravimetric analysis (glass fiber filter) periodically throughout the exposure. Particle size was measured for each exposure using a cascade impactor, and the mass median aerodynamic diameter was calculated. Chamber temperature and relative humidity were maintained within reasonable ranges for a rat and recorded hourly, and animal observations were recorded during the exposure. They were observed daily until necropsy for signs of toxicity.
The aerosol was generated using an air atomizing nozzle fed with test material using an FMI pump. The test atmosphere was directed undiluted into the exposure chamber (100 liters) housing the animals. The variations in chamber concentration was achieved by changing the pump settings. A nominal concentration was calculated based on average air flow, length of exposure, chamber volume, and the amount of test material consumed by the system.
Animals were weighed on days 0, 1, 2, 4, 7, and 14. They were sacrificed on day 14 and subjected to gross pathological examination. Surviving animals were also subjected to histopathological examination on kidneys, liver, lungs, and gross lesions.
Particle size exceeded the guideline-recommended 1-4 micron MMAD in 3 of 5 exposures. The exposure was conducted whole-body, which may have introduced an oral or dermal exposure route. Animals were noted with discolored fur. - Statistics:
- The calculation of median lethal concentration and 95% confidence intervals was performed by the method of Litchfield and Wilcoxon.
Results and discussion
- Preliminary study:
- Two of the Zoldine-ZE exposures (1.6 mg/l and 2.6 mg/l) had MMAD values of 4 microns or less. Both exposures were below the calculated LC50 (1.6 mg/l - 0/5 female, 0/5 male; 2.6 mg/l - 2/5 female, 1/5 male). Acute toxicity of the test material was concentration dependent, and female rats were more sensitive than males.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 3.1 mg/L air
- Remarks on result:
- other: 95% CI, 2.7-3.5 mg/L
- Mortality:
- All test material-dependent deaths occurred on the day of or the day after exposure. In the absence indications of systemic injury, the rapid death suggests severe irritation/injury to the respiratory tract. Histopathological examination of the lungs of the lungs of all rats failed to show treatment-related pulmonary injury. This suggests irritation/injury to the upper respiratory tract, however, no examination of the nasal airways was conducted.
- Clinical signs:
- other: At exposures of 2.6 mg/L and higher, the animals were noted huddled with eyes closed. The fur was matted and soiled. Rats were noted with increased lacrimation and perinasal soiling, salivation, and periocular soiling. Hunched posture, loss of or reduc
- Body weight:
- Body weights for surviving animals recovered to pre-exposure weights by day 4 (males) or day 7 (females). Body weights during the second week were unremarkable for all test animals, and were comparable to the control animals at termination.
- Gross pathology:
- Lung discoloration was the only macroscopic finding unique to pathology. Microscopic lung findings were similar in treated and control animals. The main changes were a thickening of the alveolar septa by lymphocytes and macrophages, accompanied by cellular exudation of macrophages and neutrophils in the aveolar lumen. The alterations were orientated around the respiratory bronchioles and surrounding alveoli. Alveoli hemorrhage was focal and mild in a few animals, and was considered to be typical of a low degree of interstitial pneumonia, a common incidental finding in the laboratory rat. Hepatic and renal findings were infrequent and spontaneous, and not considered related to treatment.
- Other findings:
- Particle size ranged from a low of 3.9 to a high of 4.7 microns (MMAD). Particle size was minimally affected by chamber aerosol concentration which suggests it reflects the inherent particle size of the test material.
Any other information on results incl. tables
Acceptable
temperatures and relative humidities were recorded during the exposures
(68-78F and 62-90%, respectively).
Particle
size distributions ranged from 3.9-4.7 microns MMAD.
Exposure Particle
Mortality
Level Size
(mg/L) (microns)
0
n.a.
0/10
1.6 3.9
0/10
2.4 4.4
1/10
2.6 4.0
3/10
3.3 4.2
7/10
4.3 4.7
8/10
Based on mortality data, the LC50 of the test material was reported to
be 3.1 mg/L (95% CI, 2.7-3.5 mg/L).
At exposures of 2.6 mg/L and higher, the animals were noted huddled with
eyes closed. The
fur was matted and soiled. Rats
were noted with increased lacrimation and perinasal soiling, salivation,
and periocular soiling. Hunched
posture, loss of or reduced righting reflex, ataxia, decreased muscle
tone, shallow and labored breathing, and gasping. Ocular
abnormalities (corneal opacities or irregularities, dull eyes, dilated
pupils, and swollen eyelids) were also noted. These
symptoms resolved slightly during the observation period. Many
animals exposed to 2.4 mg/L and higher were additionally observed with
red extremities or paws, which resolved during the post-exposure period.
Body weights for surviving animals recovered to pre-exposure weights by
day 4 (males) or day 7 (females). Body
weights during the second week were unremarkable for all test animals,
and were comparable to the control animals at termination.
Lung discoloration was the only macroscopic finding unique to pathology.
Microscopic
lung findings were similar in treated and control animals. The
main changes were a thickening of the alveolar septa by lymphocytes and
macrophages, accompanied by cellular exudation of macrophages and
neutrophils in the aveolar lumen. The
alterations were orientated around the respiratory bronchioles and
surrounding alveoli. Alveoli
hemorrhage was focal and mild in a few animals, and was considered to be
typical of a low degree of interstitial pneumonia, a common incidental
finding in the laboratory rat. Hepatic
and renal findings were infrequent and spontaneous, and not considered
related to treatment.
Applicant's summary and conclusion
- Interpretation of results:
- sligthly toxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In summary, in light of the lack of test material induced pulmonary injury, the effect of the particle size being slightly greater than 4 microns (MMAD) on the observed toxicity and estimation of the LC50 is believed to be minimal. LC50 was found to be 3.1 mg/L (95% CI, 2.7-3.5 mg/L).
- Executive summary:
Single, four-hour whole-body aerosol exposures were conducted with 5 male and 5 female Sprague-Dawley rats in order to determine the median lethal dose. Rats were obtained from a commercial supplier. They were group housed during a 14-day acclimation period to the laboratory. They were housed individually and identified by metal ear tag after assignment to study. They were given food and waterad libitumduring their stay in the testing facility.
Chamber monitoring was accomplished by gravimetric analysis (glass fiber filter) periodically throughout the exposure. Particle size was measured for each exposure using a cascade impactor, and the mass median aerodynamic diameter was calculated. Chamber temperature and relative humidity were maintained within reasonable ranges for a rat and recorded hourly, and animal observations were recorded during the exposure. They were observed daily until necropsy for signs of toxicity.
The aerosol was generated using an air atomizing nozzle fed with test material using an FMI pump. The test atmosphere was directed undiluted into the exposure chamber (100 liters) housing the animals. The variations in chamber concentration were achieved by changing the pump settings. A nominal concentration was calculated based on average air flow, length of exposure, chamber volume, and the amount of test material consumed by the system.
Animals were weighed on days 0, 1, 2, 4, 7, and 14. They were sacrificed on day 14 and subjected to gross pathological examination. Surviving animals were also subjected to histopathological examination on kidneys, liver, lungs, and gross lesions.
The calculation of median lethal concentration and 95% confidence intervals was performed by the method of Litchfield and Wilcoxon. Two of the Zoldine-ZE exposures (1.6 mg/l and 2.6 mg/l) had MMAD values of 4 microns or less. Both exposures were below the calculated LC50(1.6 mg/l - 0/5 female, 0/5 male; 2.6 mg/l - 2/5 female, 1/5 male). Acute toxicity of the test material was concentration dependent, and female rats were more sensitive than males.All test material-dependent deaths occurred on the day of or the day after exposure. In the absence indications of systemic injury, the rapid death suggests severe irritation/injury to the respiratory tract. Histopathological examination of the lungs of the lungs of all rats failed to show treatment-related pulmonary injury. This suggests irritation/injury to the upper respiratory tract, however, no examination of the nasal airways was conducted.
In summary, in light of the lack of test material induced pulmonary injury, the effect of the particle size being slightly greater than 4 microns (MMAD) on the observed toxicity and estimation of the LC50is believed to be minimal. LC50 was found to be 3.1 mg/L (95% CI, 2.7-3.5 mg/L).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
